Received USD 3.5 million milestone fee from Maruho of Japan for GI301
GI Innovation received a USD 3.5 million milestone fee from Japan's Maruho on Nov 16, 2026, after the first patient was dosed in a Phase 2 trial in Japan.
358570 · KOSDAQ · Based on DART filings
3 total · 20 per page
GI Innovation received a USD 3.5 million milestone fee from Japan's Maruho on Nov 16, 2026, after the first patient was dosed in a Phase 2 trial in Japan.
· Periodic Report
GI Innovation had no revenue from January to September and lost KRW 42.4 billion from its main business, including a KRW 15.7 billion loss in the third quarter.
· Report on Large Shareholdings
The stake of largest shareholder Jang Myung Ho and 11 related parties in GI Innovation Inc. stayed at 6.57%, with 2,114,034 of his 3,970,121 shares under pledge contracts.
Get app alerts for new disclosures from GI Innovation Inc..